GlassScriptPhysician profile
Marie Puffpaff
NPI 1881711372
$5,166.59
in general payments reported to CMS, 2019-2025
29 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $962 · 2022: $963 · 2023: $1,465 · 2024: $1,458 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,153 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,152.73 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $847.99 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $578.17 | 2021-2025 | Verquvo, Steglatro, Belsomra |
| Novartis Pharmaceuticals Corporation | $564.38 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $404.18 | 2022-2024 | Farxiga, Brilinta, Wainua |
| Janssen Pharmaceuticals, INC | $352.21 | 2021-2024 | Xarelto |
| Amgen INC. | $252.47 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $234.69 | 2021-2025 | |
| Boston Scientific Corporation | $227.93 | 2022-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Amarin Pharma, INC. | $197.46 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $162.35 | 2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $154.72 | 2022-2023 | Camzyos, Eliquis |
| Atricure, INC. | $133.64 | 2021-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $128.17 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $114.27 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $96.36 | 2025 | Wegovy, Ozempic |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $96.30 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $94.91 | 2023-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $84.31 | 2021-2024 | |
| Alnylam Pharmaceuticals INC. | $81.88 | 2021-2022 | |
| Abiomed | $76.00 | 2025 | |
| Edwards Lifesciences Corporation | $58.96 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Regeneron Healthcare Solutions, INC. | $54.06 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $40.56 | 2023 | Arcalyst |
| Medtronic, INC. | $32.10 | 2022-2023 | Venaseal |
| Kestra Medical Technology Services, INC. | $24.20 | 2022 | |
| Biosense Webster, INC. | $23.01 | 2021 | |
| Abbott Laboratories | $18.15 | 2021 | |
| Tactile Systems Technology INC | $17.90 | 2024 | Entre Plus, Flexitouch Plus |
| Impulse Dynamics (USA) INC. | $15.26 | 2023 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marie Puffpaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.